Show
Sort by
-
- Journal Article
- A1
- open access
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
-
Randomised evaluation of the benefits of G-CSF (filgrastim) during the rapid induction regimen of the European High Risk Neuroblastoma Study
-
Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.
-
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?
-
Deletion of chromosome 11q is the most frequent deletion detected by CGH in metastatic neuroblastoma lacking MYCN amplification
-
Intracranial Germ-Cell Tumors - A comprehensive Update of the European Data.